fregime
TODAYSTOCKSARCHIVEABOUTGUIDE
Sign inFollow your stocks

Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 15 Oct 2026

TATAELXSI, full dossier

Tata Elxsi reported constant currency revenue growth of 2.3%, well above expectations of 1.5%, while EBIT margins at 19.7% were higher than the CNBC-TV18 poll of 19.2% and the previous quarter's 19%.

1 publisher has reported this development. Each act of reporting is below, cited.

The record

Tata Elxsi reported constant currency revenue growth of 2.3%, well above expectations of 1.5%, while EBIT margins at 19.7% were higher than the CNBC-TV18 poll of 19.2% and the previous quarter's 19%.

cnbctv18.com14 Oct 2026

A single act of reporting so far, corroborating sources join this record as they publish.

Tata Elxsi

₹3,700.00

▲ +2.12%

Close (EOD), as of 15 Oct 2026 · source

Tata Elxsi: results, dividends, orders, the full cited record →

More on Tata Elxsi

Tata Elxsi's net profit increased by 10% on an annual basis to ₹ 170.30 crore in Q2FY27, and its revenue from operations increased by 14.98% YoY to ₹ 1,055.66 crore in Q2 FY27.

16 Oct 2026 · 10 publishers

Ventura Securities has picked 3 stocks on a technical basis that can give up to 19% return in the coming time.

16 Oct 2026 · 1 publisher

Ventura's Bharat K. Gala sees up to 24% upside potential on Tata Elxsi, Zensar Technologies, and Havells India.

16 Oct 2026 · 1 publisher

Tata Elxsi's stock rebounded as growth improved in Q2.

15 Oct 2026 · 1 publisher

Shares of Wipro, Adani Enterprises, Hero Motors, Hindustan Oil and Tata Elxsi will be in focus during the trading session on Wednesday, October 14.

15 Oct 2026 · 1 publisher

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.